• Email
  • Help

This page brings together the Agency's latest information on diabetes.

It lists:

the ten newest and recently updated medicines authorised for the treatment of diabetes in the European Union (EU);

the most recent opinions on anti-diabetes medicines that are pending authorisation by the European Commission (EC);

the latest diabetes-related news and press releases;

the Agency's events on diabetes-related topics.

New and recently updated medicines

Opinions pending EC decision